Back to results
US 2019/0240247 A1Published application
Pharmaceutical formulations of regadenoson
AssigneeLeiutis Pharmaceuticals Pvt. Ltd.
InventorsKocherlakota CHANDRASHEKHAR, Banda NAGARAJU
Life of this patent
Estimating the term…
Abstract
The present invention relates to parenteral pharmaceutical formulation of Regadenoson comprising of Regadenoson, one or more cyclodextrins and pharmaceutically acceptable excipients.
Claims5
A parenteral pharmaceutical formulation of Regadenoson comprising:
- (i) Regadenoson or a pharmaceutically acceptable salt, solvates or hydrates thereof
- (ii) one or more cyclodextrins
- (iii) one or more solvents and
- (iv) optionally other pharmaceutically acceptable excipients,
- wherein the formulation is free of propylene glycol.
2 more elements
Dependencies are inferred from the claim text.